Related Experiment Videos
Cell proliferation as a prognostic indicator in conjunctival malignant melanoma
1Division of Ophthalmic Pathology and Oncology, St. Erik's Eye Hospital, Stockholm, Sweden.
American Journal of Ophthalmology
|July 15, 1993
Summary
Proliferating cell nuclear antigen (PCNA) expression levels in conjunctival melanoma predict patient survival. Higher PCNA counts indicate a greater risk of metastatic disease and poorer prognosis.
Area of Science:
- Ophthalmology
- Oncology
- Molecular Biology
Background:
- Conjunctival malignant melanoma is a rare but aggressive ocular tumor.
- Accurate prognostic markers are crucial for guiding treatment and patient management.
Purpose of the Study:
- To investigate the prognostic value of proliferating cell nuclear antigen (PCNA) expression in conjunctival melanoma.
- To determine if PCNA cell counts correlate with patient survival and metastatic disease risk.
Main Methods:
- Immunohistochemical analysis of PCNA expression in 20 conjunctival melanoma specimens.
- Quantification of PCNA-positive cells per square millimeter.
- Statistical analysis using multifactor ANOVA and multivariate Cox regression models.
Main Results:
- PCNA cell counts were reproducible with minimal intraobserver variability.
- Significantly higher PCNA counts were observed in patients who died of metastatic disease (P = .0011).
- PCNA cell counts demonstrated independent prognostic value (P = .048), with distinct survival proportions for low and high-risk groups (90% vs. 60% five-year survival).
Conclusions:
- Total count of PCNA-expressing cells serves as a reliable prognostic indicator in conjunctival melanoma.
- PCNA expression levels can help stratify patients based on metastatic risk and survival outcomes.
- This marker aids in personalized treatment strategies for conjunctival melanoma.